HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids.

Abstract
Of 172 beagle dogs administered investigational oral contraceptive steroids for 2.4-5.2 years, 9 developed malignant mammary tumors. At necropsy their ages varied from 41 to 70 months, with a mean age of 4.9 years. The malignant tumors were observed in 1 dog that received ethynerone plus mestranol at 1.05 mg/kg/day and in 4 dogs that received chlorethynyl norgestrel plus mestranol at 1.05 mg/kg/day. Also, 4 dogs that received anagestone acetate plus mestranol at either 0.44 or 1.10 mg/kg/day developed malignant mammary tumors. Malignant tumors were not seen in 33 dogs administered mestranol at 0.02 and 0.05 mg/kg/day for 7 years or in 18 dogs given ethynerone without mestranol at 1.00 mg/kg/day for 5 years. No malignant tumors were observed in 18 control dogs maintained for 7 years without treatment. Three dogs had single malignant mammary nodules, 3 dogs had 2 malignant nodules, 2 dogs had 4-6 malignant nodules, and 1 dog in the treatment group given high dosages of ethynerone plus mestranol had 14 mammary nodules composed of fibrosarcoma. The malignant tumors were histologically classified as 5 anaplastic carcinomas, 2 solid carcinomas, 1 tubular adenocarcinoma, 1 squamous cell carcinoma, and 1 fibrosarcoma. Most dogs had only 1 histologic type of cancer (8/9 dogs); however, 1 dog had carcinomas of both solid and anaplastic types involving different glands. Metastases were present in 5 dogs and most often involved regional lymph nodes and lung.
AuthorsR P Kwapien, R C Giles, R G Geil, H W Casey
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 65 Issue 1 Pg. 137-44 (Jul 1980) ISSN: 0027-8874 [Print] United States
PMID6930510 (Publication Type: Journal Article)
Chemical References
  • Carcinogens
  • Contraceptives, Oral
  • Contraceptives, Oral, Combined
  • Norpregnadienes
  • Pregnenes
  • chloroethynyl norgestrel
  • Norgestrel
  • Mestranol
  • ethynerone
  • anagestone
Topics
  • Adenocarcinoma (chemically induced, pathology)
  • Animals
  • Carcinogens
  • Carcinoma, Squamous Cell (chemically induced, pathology)
  • Contraceptives, Oral (toxicity)
  • Contraceptives, Oral, Combined (toxicity)
  • Dogs
  • Female
  • Fibrosarcoma (chemically induced, pathology)
  • Lung Neoplasms (chemically induced, secondary)
  • Mammary Neoplasms, Experimental (chemically induced, pathology)
  • Mestranol (toxicity)
  • Norgestrel (analogs & derivatives, toxicity)
  • Norpregnadienes (toxicity)
  • Pregnenes (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: